OptimizeRx Corp. (OPRX) |
| 6.55 0.14 (2.18%) 07-13 16:00 |
| Open: | 6.455 |
| High: | 6.6 |
| Low: | 6.375 |
| Volume: | 225,946 |
| Market Cap: | 123(M) |
| PE Ratio: | 6.01 |
| Exchange: | NASDAQ |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 7.71 |
| Resistance 1: | 6.60 |
| Pivot price: | 5.70 |
| Support 1: | 5.33 |
| Support 2: | 4.54 |
| 52w High: | 22.25 |
| 52w Low: | 4.54 |
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Financials
| EPS | 0.360 |
| Book Value | 6.840 |
| PEG Ratio | 1.61 |
| Gross Profit | 4.005 |
| Profit Margin (%) | 6.37 |
| Operating Margin (%) | 2.00 |
| Return on Assets (ttm) | 5.4 |
| Return on Equity (ttm) | 5.6 |
Company news
Tue, 30 Jun 2026
OptimizeRx ties copay offers to physician intent at prescribing moment - Stock Titan
Mon, 29 Jun 2026
OptimizeRx Corporation(NasdaqCM:OPRX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Mon, 29 Jun 2026
OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Fri, 26 Jun 2026
Enterprise value to EBIT forward of OptimizeRx Corporation – NASDAQ:OPRX - TradingView
Thu, 25 Jun 2026
OptimizeRx puts HCP audience building inside ad-buying platforms - Stock Titan
Wed, 17 Jun 2026
OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
